Skip to main content
GNTA logo

Genenta Science S.p.A.

GNTANASDAQHealthcareBiotechnology

$0.63Today:- (-)1Y −80.49%

As of Oct 23, 2026 close

Market cap
$12.42M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.55$10.00
Volume (live)
-
Avg. volume (3M)
59.52K

Genenta Science S.p.A. (GNTA) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Genenta Science S.p.A. reported total assets of EUR 31.89M and total liabilities of EUR 10.05M. Shareholders' equity was EUR 21.84M, up 74.8% from EUR 12.50M a year earlier. Total debt stood at EUR 7.60M against EUR 28.15M in cash and short-term investments, a net cash position of EUR 20.55M. That puts debt-to-equity at 0.35, compared with 0.00 a year earlier.

Genenta Science S.p.A. Balance Sheet Analysis

Values in millions EUR

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Genenta Science S.p.A. (GNTA) - Annual data in millions EUR
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Current Assets
Cash and Cash Equivalents5.534.583.6929.7937.2415.4720.14
Short-Term Investments22.628.0815.080.000.000.000.00
Cash & Short-Term Investments28.1512.6618.7829.7937.2415.4720.14
Accounts Receivable1.291.452.001.561.420.000.00
Inventory0.000.000.000.140.080.03-0.16
Other Current Assets1.830.210.481.930.021.040.62
Total Current Assets29.9814.4721.2631.7238.7616.5320.60
Non-Current Assets
Property, Plant & Equipment (Net)0.020.040.060.110.020.020.00
Long-Term Investments0.000.000.000.000.000.000.00
Intangible Assets0.000.020.050.000.000.000.00
Other Non-Current Assets1.890.020.981.601.240.950.75
Total Non-Current Assets1.910.351.091.721.270.970.75
Total Assets31.8914.8222.3533.4440.0317.5021.35
Current Liabilities
Accounts Payable1.810.320.291.190.190.560.57
Short-Term Debt0.000.010.000.000.000.000.00
Accrued Liabilities0.191.261.010.690.841.73-
Other Current Liabilities0.120.341.440.300.951.781.91
Total Current Liabilities2.122.101.742.181.142.332.49
Non-Current Liabilities
Long-Term Debt7.600.000.000.000.000.000.00
Other Non-Current Liabilities0.330.000.180.120.030.020.01
Total Non-Current Liabilities7.930.230.180.120.030.020.01
Total Liabilities10.052.331.912.301.172.352.50
Stockholders' Equity
Common Stock84.2668.4667.3466.6065.880.040.04
Retained Earnings-62.59-56.06-47.14-35.47-27.02-21.49-15.90
Accumulated Other Comprehensive Income0.170.090.230.000.000.000.00
Additional Paid-in Capital0.000.000.000.000.0036.6034.71
Shares Outstanding23.4318.2918.2218.2218.22--
Total Stockholders' Equity21.8412.5020.4331.1438.8615.1518.85
Total Liabilities & Equity31.8914.8222.3533.4440.0317.5021.35

Source: Company financial statements from annual and quarterly filings. Data as of Dec 31, 2025. Data sources and methodology

Frequently Asked Questions About Genenta Science S.p.A. Balance Sheet

How much debt does Genenta Science S.p.A. have?

Genenta Science S.p.A. had total debt of EUR 7.60M as of Dec 31, 2025, against EUR 28.15M in cash and short-term investments. Its debt-to-equity ratio was 0.35. Total debt was EUR 14.60K a year earlier.

What are Genenta Science S.p.A.'s total assets?

Genenta Science S.p.A. reported total assets of EUR 31.89M as of Dec 31, 2025, up 115.1% from EUR 14.82M a year earlier. Total liabilities were EUR 10.05M.

What is Genenta Science S.p.A.'s shareholders' equity?

Genenta Science S.p.A.'s shareholders' equity was EUR 21.84M as of Dec 31, 2025, or about EUR 0.93 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition